+44 1478 350008Pancreatic Disorders & Therapy : Citations & Metrics Report
Articles published in Pancreatic Disorders & Therapy have been cited by esteemed scholars and scientists all around the world. Pancreatic Disorders & Therapy has got h-index 11, which means every article in Pancreatic Disorders & Therapy has got 11 average citations.
Following are the list of articles that have cited the articles published in Pancreatic Disorders & Therapy.
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Year wise published articles |
30 | 28 | 9 | 1 | 7 |
Year wise citations received |
43 | 44 | 64 | 43 | 36 |
| Journal total citations count | 437 |
| Journal impact factor | 1.58 |
| Journal 5 years impact factor | 3.08 |
| Journal cite score | 3.74 |
| Journal h-index | 11 |
| Journal h-index since 2018 | 9 |
Important citations (368)
Circulating pancreatic cancer exosomal rnas for detection of pancreatic cancer |
|
Endogenous glutamine decrease is associated with pancreatic cancer progression |
|
exosomal markers (cd63 and cd9) expression pattern using immunohistochemistry in resected malignant and nonmalignant pancreatic specimens |
|
outcome quality standards for surgery of colorectal liver metastasis |
|
pancreas cancer?associated weight loss |
|
bridging the gap: incorporating exercise evidence into clinical practice in breast cancer care |
|
exosomal markers (cd63 and cd9) expression and their prognostic significance using immunohistochemistry in patients with pancreatic ductal adenocarcinoma |
|
hypoxia alters the release and size distribution of extracellular vesicles in pancreatic cancer cells to support their adaptive survival. |
|
exosomes in pancreatic cancer: from early detection to treatment |
|
exosomes, their biogenesis and role in inter-cellular communication, tumor microenvironment and cancer immunotherapy. |
|
clinical implications of exosomes: targeted drug delivery for cancer treatment |
|
exosomes confer chemoresistance to pancreatic cancer cells by promoting ros detoxification and mir-155-mediated suppression of key gemcitabine-metabolising enzyme, dck. |
|
extracellular matrix proteins and carcinoembryonic antigen-related cell adhesion molecules characterize pancreatic duct fluid exosomes in patients with pancreatic cancer. |
|
comparative analysis of exosome isolation methods using culture supernatant for optimum yield, purity and downstream applications. |
|
the effect of admission serum triglyceride level on the prediction of severity of acute pancreatitis in pregnancy. |
|
the role of endoscopic ultrasound (eus) in the management of patients with pancreatic cancer: now bigger than ever |
|
Xmd8-92 inhibits pancreatic tumor xenograft growth via a dclk1-dependent mechanism |
|
dclk1 regulates pluripotency and angiogenic factors via microrna-dependent mechanisms in pancreatic cancer |
|
pancreatic surgery with vascular reconstruction in patients with locally advanced pancreatic neuroendocrine tumors |
|
novel strategies for cancer treatment: highlights from the 55th iacr annual conference. |
|